Efficacy of Long-Acting Cabotegravir and Rilpivirine for PEP in a Macaque Model of RT SHIV Infection
Background: Current recommendations for post-exposure prophylaxis (PEP) for non-occupational HIV exposures include 28 days of daily oral antiretroviral drugs. However, low adherence, and inadequate regimen completion represents an important challenge. We examined whether a single injection of the combination of long-acting cabotegravir and rilpivirine (CAB LA and RPV LA) could be an effective PEP regimen…